Societe Generale Securities Co., Ltd. on the 2023 Annual Continuous Supervision and Follow-up Report of Anhui Huaheng Biotechnology Co., Ltd.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.